Stay updated on DS-1062a vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the DS-1062a vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the DS-1062a vs Docetaxel in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link was removed from the footer, along with Revision: v3.3.2.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a Study Status field to the Record History showing the study's status for each version entry. This makes status changes across updates easier to track.SummaryDifference0.2%

- Check42 days agoChange DetectedThe revision history shows an added Revision: v3.3.2 and a removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe notice about government funding delays and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedThe latest view adds version entries with updates to Study Status and Contacts/Locations in the history, reflecting ongoing changes to the trial’s status and management.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference9%

Stay in the know with updates to DS-1062a vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS-1062a vs Docetaxel in Lung Cancer Clinical Trial page.